(-1.01%) 5 064.54 points
(-1.06%) 37 981 points
(-1.22%) 15 787 points
(-1.42%) $81.46
(-2.07%) $1.988
(-2.12%) $2 307.80
(-3.54%) $26.68
(-1.30%) $949.00
(0.41%) $0.936
(0.92%) $11.08
(0.44%) $0.800
(0.15%) $93.44
2 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 12.23%
@ $14.22
发出时间: 14 Feb 2024 @ 22:32
回报率: 29.48%
上一信号: Feb 13 - 22:30
上一信号:
回报率: -0.21 %
Live Chart Being Loaded With Signals
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy...
Stats | |
---|---|
今日成交量 | 435 421 |
平均成交量 | 1.19M |
市值 | 1.87B |
EPS | $0 ( 2024-03-04 ) |
下一个收益日期 | ( $-0.250 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.21 |
ATR14 | $0.0300 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-20 | Kim Richard J | Buy | 147 000 | Stock Option (Right to Buy) |
2024-02-20 | Mchugh Thomas S | Buy | 157 500 | Stock Option (Right to Buy) |
2024-02-20 | Divis Gregory J | Buy | 600 000 | Stock Option (Right to Buy) |
2024-01-16 | Mchugh Thomas S | Buy | 2 000 | ADSs |
2023-12-28 | Mccamish Mark Anthony | Sell | 75 000 | ADSs |
INSIDER POWER |
---|
81.01 |
Last 94 transactions |
Buy: 6 417 800 | Sell: 317 647 |
音量 相关性
Avadel Pharmaceuticals 相关性 - 货币/商品
Avadel Pharmaceuticals 财务报表
Annual | 2023 |
营收: | $27.96M |
毛利润: | $25.35M (90.66 %) |
EPS: | $-2.00 |
FY | 2023 |
营收: | $27.96M |
毛利润: | $25.35M (90.66 %) |
EPS: | $-2.00 |
FY | 2022 |
营收: | $0 |
毛利润: | $-1.49M (0.00 %) |
EPS: | $-2.29 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.320 |
Financial Reports:
No articles found.
Avadel Pharmaceuticals
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。